News

  • Theradaptive selected for Phase II funding under the Defense Health Program Small Business Innovation Research Program to develop orthopedic repair implants with biologic delivery capability. 

  • Theradaptive partners on a $1.47M DoD Contract to develop next-gen 3D printed drug-eluting spinal fusion devices

© 2017-2019 by Theradaptive, Inc.